Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study

Abstract Background and aims Hereditary transthyretin amyloidosis (ATTRv) should be considered in patients diagnosed with intravenous immunoglobulin (IVIg)-resistant chronic inflammatory demyelinating polyradiculoneuropathy (IVIg-NR CIDP). In this 1-year long, retrospective, multicentric study, an o...

Full description

Saved in:
Bibliographic Details
Main Authors: Yann Péréon, David Adams, Jean-Philippe Camdessanché, Jean-Baptiste Chanson, Pascal Cintas, Laurent Magy, Aïssatou Signaté, Guilhem Solé, Juliette Svahn, Céline Tard, Cyrla Hababou, Shahram Attarian
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Online Access:https://doi.org/10.1186/s13023-025-03589-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850237827593273344
author Yann Péréon
David Adams
Jean-Philippe Camdessanché
Jean-Baptiste Chanson
Pascal Cintas
Laurent Magy
Aïssatou Signaté
Guilhem Solé
Juliette Svahn
Céline Tard
Cyrla Hababou
Shahram Attarian
author_facet Yann Péréon
David Adams
Jean-Philippe Camdessanché
Jean-Baptiste Chanson
Pascal Cintas
Laurent Magy
Aïssatou Signaté
Guilhem Solé
Juliette Svahn
Céline Tard
Cyrla Hababou
Shahram Attarian
author_sort Yann Péréon
collection DOAJ
description Abstract Background and aims Hereditary transthyretin amyloidosis (ATTRv) should be considered in patients diagnosed with intravenous immunoglobulin (IVIg)-resistant chronic inflammatory demyelinating polyradiculoneuropathy (IVIg-NR CIDP). In this 1-year long, retrospective, multicentric study, an online questionnaire was sent to 1100 French healthcare professionals (HCPs) investigating: (i) how many IVIg-NR CIDP patients they followed; (ii) how many IVIg-NR CIDP patients had undergone TTR gene analysis; and (iii) how many IVIg-NR CIDP patients were eventually diagnosed with ATTRv. The questionnaire was sent every 3 months for 1 year and contained information on ATTRv clinical manifestations and diagnosis. Results One-hundred and ten (10%) HCPs responded. A total of 2131 patients with CIDP were identified, including 315 (22.1%) with IVIg-NR CIDP. TTR gene analysis was performed in 144 patients and was positive in 43 cases (29.9%). Conclusions This study demonstrates that ATTRv should be investigated systematically in patients diagnosed with IVIg-NR CIDP. HCP-directed information campaigns are useful for modifying diagnostic practices.
format Article
id doaj-art-8eba2ede778d4e22a5fd982ee67d9181
institution OA Journals
issn 1750-1172
language English
publishDate 2025-03-01
publisher BMC
record_format Article
series Orphanet Journal of Rare Diseases
spelling doaj-art-8eba2ede778d4e22a5fd982ee67d91812025-08-20T02:01:39ZengBMCOrphanet Journal of Rare Diseases1750-11722025-03-012011710.1186/s13023-025-03589-4Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective studyYann Péréon0David Adams1Jean-Philippe Camdessanché2Jean-Baptiste Chanson3Pascal Cintas4Laurent Magy5Aïssatou Signaté6Guilhem Solé7Juliette Svahn8Céline Tard9Cyrla Hababou10Shahram Attarian11Centre de Référence Maladies Neuromusculaires AOC, Filnemus, Euro-NMD, Hôtel-Dieu, CHU de NantesDépartement de Neurologie, Centre de Référence Neuropathies Rares CERAMIC, CHU de Bicêtre, Université Paris-SaclayDepartment of Neurology, Reference Centre for Neuromuscular Diseases, Hôpital Nord, University Hospital of Saint-EtienneService de Neurologie, Hôpitaux Universitaires de Strasbourg et Centre de Référence NeuromusculaireHôpital Pierre Paul Riquet, Centre de Référence de Pathologie NeuromusculaireService et Laboratoire de Neurologie, Centre de Référence National Neuropathies Périphériques Rares, Centre Hospitalier Universitaire DupuytrenService de Neurologie, Centre Hospitalier Universitaire de MartiniqueCentre de Référence des Maladies Neuromusculaires AOC, Service de Neurologie et des Maladies Neuromusculaires, Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux Service de Pathologies Neuromusculaires, Hôpital Pierre Wertheimer, Hospices Civils de LyonService de Neurologie, CHU de Lille, Centre de Référence des Maladies Neuromusculaires Nord/Est/Ile-de-FranceLaboratoire AlnylamCentre de Référence des Maladies Neuromusculaires et de la SLA, CHU la Timone, Aix-Marseille UniversitéAbstract Background and aims Hereditary transthyretin amyloidosis (ATTRv) should be considered in patients diagnosed with intravenous immunoglobulin (IVIg)-resistant chronic inflammatory demyelinating polyradiculoneuropathy (IVIg-NR CIDP). In this 1-year long, retrospective, multicentric study, an online questionnaire was sent to 1100 French healthcare professionals (HCPs) investigating: (i) how many IVIg-NR CIDP patients they followed; (ii) how many IVIg-NR CIDP patients had undergone TTR gene analysis; and (iii) how many IVIg-NR CIDP patients were eventually diagnosed with ATTRv. The questionnaire was sent every 3 months for 1 year and contained information on ATTRv clinical manifestations and diagnosis. Results One-hundred and ten (10%) HCPs responded. A total of 2131 patients with CIDP were identified, including 315 (22.1%) with IVIg-NR CIDP. TTR gene analysis was performed in 144 patients and was positive in 43 cases (29.9%). Conclusions This study demonstrates that ATTRv should be investigated systematically in patients diagnosed with IVIg-NR CIDP. HCP-directed information campaigns are useful for modifying diagnostic practices.https://doi.org/10.1186/s13023-025-03589-4Chronic inflammatory demyelinating polyradiculoneuropathyHereditary transthyretin amyloidosisIntravenous immunoglobulins
spellingShingle Yann Péréon
David Adams
Jean-Philippe Camdessanché
Jean-Baptiste Chanson
Pascal Cintas
Laurent Magy
Aïssatou Signaté
Guilhem Solé
Juliette Svahn
Céline Tard
Cyrla Hababou
Shahram Attarian
Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
Orphanet Journal of Rare Diseases
Chronic inflammatory demyelinating polyradiculoneuropathy
Hereditary transthyretin amyloidosis
Intravenous immunoglobulins
title Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
title_full Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
title_fullStr Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
title_full_unstemmed Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
title_short Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study
title_sort diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins results of a retrospective study
topic Chronic inflammatory demyelinating polyradiculoneuropathy
Hereditary transthyretin amyloidosis
Intravenous immunoglobulins
url https://doi.org/10.1186/s13023-025-03589-4
work_keys_str_mv AT yannpereon diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT davidadams diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT jeanphilippecamdessanche diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT jeanbaptistechanson diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT pascalcintas diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT laurentmagy diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT aissatousignate diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT guilhemsole diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT juliettesvahn diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT celinetard diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT cyrlahababou diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy
AT shahramattarian diagnosisofhereditarytransthyretinamyloidosisinpatientswithsuspectedchronicinflammatorydemyelinatingpolyneuropathyunresponsivetointravenousimmunoglobulinsresultsofaretrospectivestudy